Peripatetics pass in front of a Nordstrom Inc. store in the Midtown neighborhood of New York, on March 20, 2020.
Gabby Jones | Bloomberg | Getty Facsimiles
Check out the companies making headlines after the bell Wednesday:
Nordstrom — The retailer’s stock fell assorted than 3% after the retailer said its holiday period sales dropped 22% on a year-over-year basis. Regard for the drop, CEO Erik Nordstrom said the company sees momentum picking up following the holiday season “as we continue to unlock new forward movement to better serve customers on their terms with greater convenience and connection.”
Ethan Allen — Shares of the accouterments company rose 4.8% on the back better-than-expected earnings guidance for the fiscal second quarter. Ethan Allen affirmed it expects earnings per share to range between 67 cents per share and 69 cents per share, topping a FactSet sentiment of 46 cents per share. “Despite many challenges due to the ongoing COVID-19 pandemic, we had a strong performance,” said CEO Farooq Kathwari in a announcement.
Organogenesis — Shares of the medical company surged more than 25%. Organogenesis reported preliminary revenue total for 2020 that exceeded estimates. The company said full-year 2020 sales ranged between $336.1 million and $337.5 million. Analysts expected interest of $312.3 million.